Galleri Multi-Cancer Early Detection Test vs TruDiagnostic TruAge COMPLETE Epigenetic Test
Specs, prices, editor verdict, and who should buy which - compared side-by-side.
Galleri Multi-Cancer Early Detection Test (premium, $949/test) vs TruDiagnostic TruAge COMPLETE Epigenetic Test (premium, $499–$849/test) - different tools for different jobs (see the per-product details below).
Compared on 0 shared specs · same category (diagnostic).
These are close picks. Both score in the same range. The right call depends on buyer profile - read the per-buyer recommendations below.
Who should buy which
Buyers over 50, those with family cancer history, longevity-focused spenders adding a screening layer to standard surveillance.
You're under 40 with no family history (false-positive math is unfavorable), or you can't afford the follow-up imaging if it triggers.
Longevity-focused buyers running serious anti-aging protocols who want validated pace-of-aging tracking, and biomarker-literate users adding epigenetic data to a broader monitoring stack.
You want actionable health recommendations (Function Health or InsideTracker beat it on that), you won't commit to longitudinal retests (single-point readings are noisy), or you're shopping for vanity rather than research-grade data.
Go deeper
Frequently asked
Which is better, the Galleri Multi-Cancer Early Detection Test or the TruDiagnostic TruAge COMPLETE Epigenetic Test?
They are closely matched on our scoring, so the right pick comes down to your priorities. The verdict and spec table above compare them on price, features, and who each one suits.
How much do they cost?
Galleri Multi-Cancer Early Detection Test: $949. TruDiagnostic TruAge COMPLETE Epigenetic Test: $499 to $849. Prices are verified against the manufacturer; check the live links for current pricing.
Who should buy which one?
Galleri Multi-Cancer Early Detection Test: Buyers over 50, those with family cancer history, longevity-focused spenders adding a screening layer to standard surveillance. TruDiagnostic TruAge COMPLETE Epigenetic Test: Longevity-focused buyers running serious anti-aging protocols who want validated pace-of-aging tracking, and biomarker-literate users adding epigenetic data to a broader monitoring stack.